Anbio Biotechnology Net Worth
Anbio Biotechnology Net Worth Breakdown | NNNN |
Anbio Biotechnology Net Worth Analysis
Anbio Biotechnology's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Anbio Biotechnology's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Anbio Biotechnology's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Anbio Biotechnology's net worth analysis. One common approach is to calculate Anbio Biotechnology's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Anbio Biotechnology's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Anbio Biotechnology's net worth. This approach calculates the present value of Anbio Biotechnology's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Anbio Biotechnology's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Anbio Biotechnology's net worth. This involves comparing Anbio Biotechnology's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Anbio Biotechnology's net worth relative to its peers.
Enterprise Value |
|
To determine if Anbio Biotechnology is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Anbio Biotechnology's net worth research are outlined below:
| Anbio Biotechnology is way too risky over 90 days horizon | |
| Anbio Biotechnology appears to be risky and price may revert if volatility continues | |
| Latest headline from finance.yahoo.com: Here Is What You Need To Know Before Investing In Anbio Biotechnology |
Follow Anbio Biotechnology's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.32 B.Market Cap |
|
Project Anbio Biotechnology's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.13 | 0.12 | |
| Return On Capital Employed | 0.12 | 0.11 | |
| Return On Assets | 0.13 | 0.12 | |
| Return On Equity | 0.14 | 0.13 |
When accessing Anbio Biotechnology's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Anbio Biotechnology's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Anbio Biotechnology's profitability and make more informed investment decisions.
Evaluate Anbio Biotechnology's management efficiency
Anbio Biotechnology Class has return on total asset (ROA) of 0.0718 % which means that it generated a profit of $0.0718 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1483 %, meaning that it created $0.1483 on every $100 dollars invested by stockholders. Anbio Biotechnology's management efficiency ratios could be used to measure how well Anbio Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of July 2025, Return On Tangible Assets is likely to drop to 0.12. In addition to that, Return On Capital Employed is likely to drop to 0.11. At this time, Anbio Biotechnology's Non Current Assets Total are very stable compared to the past year. As of the 22nd of July 2025, Non Currrent Assets Other is likely to grow to about 406.8 K, while Total Assets are likely to drop about 14.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.41 | 0.43 | |
| Tangible Book Value Per Share | 0.41 | 0.43 | |
| Enterprise Value Over EBITDA | 90.49 | 85.97 | |
| Price Book Value Ratio | 14.19 | 13.48 | |
| Enterprise Value Multiple | 90.49 | 85.97 | |
| Price Fair Value | 14.19 | 13.48 | |
| Enterprise Value | 232.3 M | 220.6 M |
Leadership effectiveness at Anbio Biotechnology Class is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Enterprise Value Revenue 250.5376 | Revenue | Quarterly Revenue Growth (0.36) | Revenue Per Share | Return On Equity |
Anbio Biotechnology Corporate Filings
| 28th of April 2025 Other Reports | ViewVerify | |
6K | 21st of February 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 19th of February 2025 Other Reports | ViewVerify | |
| 18th of February 2025 Certification of the accuracy of the financial statements and disclosures | ViewVerify |
Anbio Biotechnology Earnings per Share Projection vs Actual
When determining whether Anbio Biotechnology Class offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anbio Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anbio Biotechnology Class Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anbio Biotechnology Class Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Anbio Biotechnology Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anbio Biotechnology. If investors know Anbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anbio Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.06 | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Anbio Biotechnology Class is measured differently than its book value, which is the value of Anbio that is recorded on the company's balance sheet. Investors also form their own opinion of Anbio Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Anbio Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anbio Biotechnology's market value can be influenced by many factors that don't directly affect Anbio Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anbio Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anbio Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anbio Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.